575 Results (Page 19 of 23)
China Markets Research Reports
China Prenatal Testing & Newborn Screening Market Analysis
China Prenatal Testing & Newborn Screening Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Prenatal Testing & Newborn Screening is expanding as a result of rising genetic disorders and advancement in technology. These factors along with increasing fetal mortality rate are growing and boosting the Prenatal Testing & Screening market. Some of the key players in the global Prenatal Testing & Newborn Screening Market include PerkinELmer Inc., Natera, Inc., Invitae Corporation, Centogene N.V., Cradle Genomics, Hoffmann-La Roche Ltd., Quest Diagnostics, Baebies, Inc., Ravgen, and Eurofins Scientific.
China Preventive Healthcare Technologies and service Market Analysis
China Preventive Healthcare Technologies and Service Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Preventive Healthcare Technologies and Service is expanding as a result of rising incidence of chronic diseases and growing awareness among people. This demand is fueling the growth of Preventive Healthcare Technologies and Service market. Some of the key players in the global Preventive Healthcare Technologies and Service Market include Myriad Genetics, Inc., Quest Diagnostics Incorporated, Medtronic, Abbott, Merck & Co., GlaxoSmithKline plc, Omnicell, Inc., McKesson Corporation, Pfizer Inc., Dilon Medical Technologies, Inc., OMRON Healthcare Europe B.V., Novx Systems, Corp., U-Systems, Ltd., Viatronix, Inc., and Sanofi.
China Residential Nursing Care service Market Analysis
China Residential Nursing Care Service Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Residential Nursing Care Service is expanding as a result of rise in chronic diseases with growing geriatric population and growing nuclear families. This is fueling the demand for Residential Nursing Care Service market to provide support to these people. Some of the key players in the global Residential Nursing Care Service Market include The Ensign group, Inc., Kindred Healthcare, LLC, Genesis Healthcare, Brookdale Senior Living, Kaiser Permanente, CBI Health Group Inc., Trinity Health, Columbia Asia, Apollo Hospitals Enterprise Ltd., Grand World Elder Care, Knight Health Holdings, LLC, Inc., and Grand World Elder Care.
China Residential Substance Abuse and Mental Health Facilities Market Analysis
China Residential Substance Abuse and Mental Health Facilities Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Residential Substance Abuse and Mental Health Facilities is expanding as a result of rising prevalence of mental health disorders, innovation in healthcare, and improvements in healthcare infrastructure. This demand is growing the market for Residential Substance Abuse and Mental Health Facilities as more people avail these services. Some of the key players in the global Residential Substance Abuse and Mental Health Facilities Market Kaiser Permanente, Universal Health Services, Ohio Department of Mental Health and Addiction Services, NHS England, Acadia Healthcare Company, CareTech Holdings PLC, Pyramid Healthcare, The MENTOR Network, Behavioral Health Network, Inc., and Strategic Behavioral Health.
China Retirement Communities Market Analysis
China Retirement Communities Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Retirement Communities is expanding as a result of growing baby boomers and changing social norms of the family. This is fueling the demand for Retirement Communities market to provide support to these people. Some of the key players in the global Retirement Communities Market include Brookdale Senior Living Inc., Sunrise Senior Living, Atria Senior Living Group, Life Care Centers of America, Erickson Living, Holiday Retirement, Senior Lifestyle Corp., Affinity Living Group, HC-One Ltd., and Covenant Retire Communities Inc.
China Revenue Cycle Management Market Analysis
China Revenue Cycle Management Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The Revenue Cycle Management market is expanding due to huge growth opportunities created by expanding SMEs across the regions and increasing demand for workflow optimization in both developed and developing nations. This demand is fueling the development of better software systems and procedures for Revenue Cycle Management. Some of the key players in the global Revenue Cycle Management Market include Cerner Corporation, Epic Systems Corporation, Allscripts Healthcare Solutions, Inc., Athenahealth, Inc., McKesson Corporation, GE Healthcare, Quest Diagnostics, NextGen Healthcare, Inc., eClinicalWorks, and R1 RCM Inc.
China Revenue Cycle Management Software Market Analysis
China Revenue Cycle Management Software Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Revenue Cycle Management Software is expanding as a result of huge growth opportunities created by expanding SMEs across the regions and increasing demand for workflow optimization in both developed and developing nations. This demand is fueling the development of better software systems and procedures for Revenue Cycle Management. Some of the key players in the global Revenue Cycle Management Software Market include Cerner Corporation, Epic Systems Corporation, McKesson Corporation, Allscripts Healthcare Solutions, Inc., Athenahealth, Inc., eClinicalWorks LLC, GE Healthcare, NextGen Healthcare, Inc., Quest Diagnostics Incorporated, and Siemens Healthineers AG.
China Sepsis Diagnostic Market Analysis
China Sepsis Diagnostics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Sepsis diagnostics is expanding as a result of the growing burden of infectious diseases and government initiatives and funding in both developed and developing nations. This demand is fueling the development of better diagnostic tools and methods for early diagnosis of sepsis. Some of the key players in the global Sepsis Diagnostics Market include bioM?rieux SA; Becton, Dickinson & Company; Thermo Fisher Scientific, Inc.; F. Hoffmann-La Roche AG; Danaher Corp. (Beckman Coulter, Inc.); Luminex Corp.; Bruker Corp.; Cepheid, Bruker Corporation, Immunexpress, Inc., and Koninklijke Philips N.V.
China Skilled Nursing Market Analysis
China Skilled Nursing Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Skilled Nursing is expanding as a result of increasing geriatric population and increasing prevalence of chronic disease. Increasing demand for post-acute are is also fueling the need for specialized and skilled nursing in developing and developed countries. Some of the key players in the global Skilled Nursing Market include Genesis Healthcare Inc., Brookdale Senior Living Inc., Ensign Group Inc., Life Care Centers of America, Kindred Healthcare Inc., Extendicare Inc., Sunrise Senior Living, Atria Senior Living, SavaSeniorCare Administrative Services LLC., and Consulate Health Care.
China Soft Tissue Repair Market Analysis
China Soft Tissue Repair Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Soft Tissue Repair is expanding as a result of increasing sports-related injuries and a rising aging population. Increasing demand for non-invasive treatment and advancements in technology are fueling the soft tissue repair market. Some of the key players in the global soft tissue repair market are Smith & Nephew, Arthrex, Stryker Corporation, Baxter, Johnson & Johnson, Medtronic, LifeNet Health, Becton, Dickinson and Company, Integra Life Sciences Corporation, CryoLife, Boston Scientific Corporation, Zimmer Biomet, Baxter International, ACell, Tissue Regenix Group, and Aroa Biosurgery.
China Spinal Implant Market Analysis
China Spinal Implants Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Spinal Implants is expanding as a result of the rising prevalence of Spinal disorders, injuries, and fractures and the rising demand for advanced medical technology. Spinal cord injuries (SCI) are most common during road accidents and all of these spinal disorders are fueling the development of better procedures and devices for the implantation procedure of the spine. Some of the key players in the global Spinal Implants Market include Medtronic, Zimmer Biomet, Alphatec Spine Inc., RTI Surgical, Stryker, Orthofix US LLC, NuVasive Inc., Globus Medical, Aesculap Inc., Apollo Hospitals Enterprise Ltd., Centinel Spine LLC, Premia Spine, Exactech Inc., Aesculap Inc., Lumitex LLC, Life Spine Inc., and Integra LifeSciences
China Stem Cell/Cord Blood Banking Market Analysis
China Stem Cell/Cord Blood Banking Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Stem Cell/ Cord Blood Banking is expanding as a result of increase in healthcare and growing awareness among people. This demand is fueling the development of market for Stem Cell/Cord Blood Banking. Some of the key players in the global Stem Cell/Cord Blood Banking Market include CBR Systems, Inc., Cordlife, Cryo-Cell International, Inc., ViaCord, Cryo-Save, LifeCell International Pvt. Ltd., StemCyte India Therapeutics Pvt. Ltd., Global Cord Blood Corporation, Smart Cells International Limited, and Vita 34 International.
China Stroke Management and Care Market Analysis
China Stroke Management and Care Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Stroke Management and Care is growing as a result of rising prevalence of cardiovascular diseases, growing geriatric population, and advancements in technology. This demand is fueling the development of better care and management for stroke. Some of the key players in the global Stroke Management and Care Market include Abbott Laboratories, B Braun Melsungen AG, Boston Scientific Corporation, Bristol Myers Squibb Co., Merck & Co., GE Healthcare, Siemens AG, Cardinal Health Inc., GlaxoSmithKline Plc, and Medtronic Plc.
China Synthetic Biology Market Analysis
China Synthetic Biology Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Synthetic Biology is expanding as a result of rising demand for advancement in gene editing technology and genetic engineering in both developed and developing nations. This demand is fueling the development of better devices and methods for synthetic biology. Some of the key players in the global synthetic biology Market include Bota Biosciences Inc.; Codexis, Inc.; Creative Biogene; CREATIVE ENZYMES; Enbiotix, Inc.; Illumina, Inc.; Merck Kgaa (Sigma-Aldrich Co. LLC); New England Biolabs; Euro fins Scientific; Novozymes; Pareto Bio, Inc.; Scarab Genomics, LLC; Synthego; Synthetic Genomics Inc.; and Thermo Fisher Scientific, Inc.
China Thrombocytopenia Market Analysis
China Thrombocytopenia Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Thrombocytopenia is expanding as a result of increasing prevalence of thrombocytopenia and development of new treatment options. This demand is fueling the development of better devices and methods for the early and accurate diagnosis and treatment of Thrombocytopenia. Some of the key players in the global Thrombocytopenia Market include Sanofi, Principia Biopharma, Baxalta, Takeda, Argenx, Millennium Pharmaceuticals, Biotest, GC Pharma, Genosco (Subsidiary of Oscotec), Rigel Pharmaceuticals, Kissei Pharmaceutical, Shionogi & Co., Ltd, Amgen, Novartis, and Zenyaku Kogyo.
China Ultrasonic Technology Market Analysis
China Ultrasonic Technology Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Ultrasonic Technology is expanding as a result of rising chronic diseases and innovations in healthcare. This demand is fueling the growth of ultrasonic technology for the early detection and accurate diagnosis of various disease. Some of the key players in the global Ultrasonic Technology Market include Advanced Sonics, LLC, Crest Ultrasonics Corp., DPR Ultrasonic Technologies, Emerson Electric Co. (Branson), International Ultrasonic Technologies, Mosca GmbH, MS Industries AG, Sonotronic Nagel GmbH, Telsonic AG, and Ultrasonic Technologies, Inc.
China Urgent Care Center Market Analysis
China Urgent Care Center Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Urgent Care Center is expanding as a result of favorable government policies and increasing prevalence of chronic diseases and accidents. This demand is fueling the development of better infrastructures and facilities for urgent care center. Some of the key players in the global Urgent Care center market include Concentra, Inc.; American Family Care; CityMD Urgent Care; MedExpress Urgent Care; NextCare Urgent Care; Tenet Health Urgent Care; FastMed Urgent Care; Ascension Health Urgent Care; WellNow Urgent Care; Sutter Health; Aurora Urgent Care; and Intuitive Health.
China DNA Sequencing Market Analysis
China DNA Sequencing Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for DNA Sequencing is expanding as a result of advances in DNA Sequencing technology and increased applications in clinical diagnosis drug discovery. This is raising the demand for the market and is leading to increased investment in research & development for DNA Sequencing. Some of the key players in the global DNA Sequencing Market include Aglient Technologies, Illumina, Inc., Hoffmann-La Roche Ltd., QIAGEN, Perkin Elmer, Thermo Fisher Scientific, Macrogen, Inc., Bio-Rad Laboratories, Inc., Oxford Nanopore Technologies Ltd., Myriad Genetic, and Pacific Biosciences.
China Diabetes Therapeutics Market Analysis
China's diabetes therapeutics market is expected to grow from $11.56 Bn in 2022 to $27.04 Bn in 2030 with a CAGR of 11.2% for the forecasted year 2022-2030. The rise in the ageing population of China and the introduction of novel therapeutic options in China are the major growth drivers of the market. The China diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Yunnan Baiyao, Kangmei Pharmaceutical, and Eli Lilly are the major players in the China diabetes therapeutics market.
China Cancer Immunotherapy Market Analysis
China's cancer immunotherapy market is expected to grow from $9.04 Bn in 2022 to $17.50 Bn in 2030 with a CAGR of 8.6% for the forecasted year 2022-2030. A larger patient pool suffering from cancer in China and the increased funding from the Chinese government for R&D in cancer immunotherapy are driving the growth of the market. The China cancer immunotherapy market is segmented by type, application, and end user. BeiGene, Legend Biotech, and AstraZeneca are the major players in the China cancer immunotherapy market.
China Digital Health Market Analysis
China's Digital Health market is projected to grow from $16.96 Bn in 2022 to $73.42 Bn by 2030, registering a CAGR of 20.1% during the forecast period of 2022-30. Driven by national initiatives, population expansion, and diversified healthcare requirements, China's healthcare industry is experiencing faster innovation and adoption. The market is segmented by solution, by deployment, and by end-use. Some of the major players include Alibaba Group Holding Limited, Ping An Good Doctor & Cerner Corporation.
China Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market Analysis
China's Chronic Obstructive Pulmonary Disease (COPD) therapeutics market was valued at $1.46 Bn in 2022 and is estimated to expand at a CAGR of 8.6% from 2022 to 2030 and will reach $2.84 Bn in 2030. One of the main reasons propelling the growth of this market is the increased prevalence rate, air pollution, and smoking. The market is segmented by drug class and by distribution channel. Some key players in this market are Sinopharm Group, Hutchison China MediTech, Zhejiang Hisun Pharmaceutical, Haisco Pharmaceutical Group, Shanghai Sine Promod Pharmaceutical, Astellas Pharma, AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Novartis, Pfizer, Teva China Limited and others.
China Dermatology Drugs Market Analysis
By 2030, it is anticipated that the China Dermatology drugs market will reach a value of $3.46 Bn from $1.37 Bn in 2022, growing at a CAGR of 12.3% during 2022-2030. The dermatology drug market in China is dominated by a few large pharmaceutical companies such as Johnson and Johnson Shanghai, China Resources Pharmaceutical Group and Chongqing Huapont Pharm. The dermatology drug market in China is segmented by drug class, drug type, prescription mode, indication, route of administration, end-user, and distribution channel. The major factors affecting the China dermatology drugs market are the increasing disease burden of non-communicable diseases like cancer and the lack of healthcare facilities for cancer treatment in most areas of China.
China Telemedicine Market Analysis
China's telemedicine market size is at around $4.88 Bn in 2022 and is projected to reach $20.6 Bn in 2030, exhibiting a CAGR of 19.7% during the forecast period 2022-2030. China's Telemedicine Market is segmented by component, modality, delivery mode, and facility. Changes in healthcare insurance coverage and restrictions have a substantial impact on people's out-of-pocket expenses, which fuels the Chinese telemedicine market's demand. Some of the top players are Ping An Healthcare & Technology Co., Alibaba Health Information Technology Ltd., JD Health International Inc., and Medix.
China ECG Equipments Market Analysis
The China ECG Equipment Market is expected to witness growth from $716 Mn in 2022 to $1406 Mn in 2030 with a CAGR of 8.80% for the forecasted year 2022-2030. In China, heart illness is one of the main causes of death and is becoming more common. Due to this, the need for ECG equipment to diagnose and track heart disease is on the rise. The market is segmented by product type and by the end user. Some key players in this market include Mindray, Edan Instruments, Johnson & Johnson, Philipps Healthcare, Medtronic, Biolight and Dexcom.
